Back to Results
First PageMeta Content
Drugs / Pharmaceuticals policy / Alcohols / Piperidines / Fexofenadine / Over-the-counter drug / Pharmaceutical drug / Prescription medication / Food and Drug Administration / Pharmacology / Medicine / Pharmaceutical sciences


Document Date: 2001-03-15 10:04:58

Open Document

File Size: 130,15 KB

Share Result on Facebook

City

Kansas City / /

Company

WellPoint Health Networks / M.P.H. / /

Continent

Europe / /

Country

United States / Canada / /

Currency

pence / /

Facility

California Pharmacy / /

/

IndustryTerm

antihistamine/decongestant products / quality pharmaceutical care / /

MedicalCondition

allergy / nasal congestion / /

MedicalTreatment

adjunctive therapy / /

Organization

Food and Drug Administration / Regulatory Policy Division / /

Person

Rob Seidman / Blue Cross / Marion Roussel / Douglas Schur / /

/

Position

physician / Director of Regulatory Affairs / MPH Vice President / Vice President / /

Product

Allegra / fexofenadine / /

ProvinceOrState

Missouri / California / /

PublishedMedium

the FDA review / /

SocialTag